Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

Why precision medicine?

Precision medicine and PMI

Please note: Once you watch the video, data will be transmitted to Youtube/Google. For more information, see Google Privacy.

Cluster news

Skeletal remains in the ground

Risk gene increased susceptibility to paratyphoid fever in medieval Europe

Gene variant associated with medieval paratyphoid fever outbreaks today increases the risk of inflammatory diseases.

 
A scientist in a lab

New options for sustainable antibiotic therapy

Efficacy of available antibiotics could be maintained by sequentially administering closely related agents

 
Three young women with bouquets and certificates

Prestigious funding for outstanding female scientists in inflammation research

The Cluster of Excellence PMI awards three of its most exceptional young female researchers in Kiel and Lübeck a total of €200,000 in funding via its Dorothea Erxleben Female Investigator Award.

 

Random effects make it difficult to optimise antibiotic therapy

Research team from the Kiel Evolution Center investigates the role of a reduction in bacterial population size and resulting random effects in the evolution of antibiotic resistance.